Clinical Efficacy of Ceftazidime for Bacterial Lower Respiratory Infection in Children
Xiaojun Tang
Abstract
Xiaojun Tang
Abstract
OBJECTIVE:To explore the clinical efficacy and safety of ceftazidime for bacterial lower respiratory infection in children.METHODS:80 children with bacterial lower respiratory infection were randomly assigned to either intervention group(n = 40 cases) treated with ceftazidime 60 mg·kg-1 ·d-1 i.v in two divided doses or the control group(n = 40 cases) treated with ampicillin sodium 100 ~ 200 mg·kg-1·d-1 i.v in two divided doses for 5 days followed by comparison of the clinical efficacy between the two groups.RESULTS:The clinical efficacy of the intervention group vs.the control group was 95.00% vs.72.50% and the incidence of the adverse effect was 10.00% and 25.00%,and the differences were all significant(P 0.05).CONCLUSION:Ceftazidime is safe and effective for bacterial lower respiratory infection in children,and hence is worthy of being recommended in clinical practice.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE:To explore the clinical efficacy and safety of ceftazidime for bacterial lower respiratory infection in children.METHODS:80 children with bacterial lower respiratory infection were randomly assigned to either intervention group(n = 40 cases) treated with ceftazidime 60 mg·kg-1 ·d-1 i.v in two divided doses or the control group(n = 40 cases) treated with ampicillin sodium 100 ~ 200 mg·kg-1·d-1 i.v in two divided doses for 5 days followed by comparison of the clinical efficacy between the two groups.RESULTS:The clinical efficacy of the intervention group vs.the control group was 95.00% vs.72.50% and the incidence of the adverse effect was 10.00% and 25.00%,and the differences were all significant(P 0.05).CONCLUSION:Ceftazidime is safe and effective for bacterial lower respiratory infection in children,and hence is worthy of being recommended in clinical practice.
Key concepts: Ceftazidime, Medicine, Respiratory system, Incidence (geometry), Clinical efficacy, Internal medicine, Ampicillin, Respiratory infection